Immediate Impact
8 from Science/Nature 67 standout
Citing Papers
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 Standout
Works of Linda Sun being referenced
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
2013
A Study to Determine the Effects of Food and Multiple Dosing on the Pharmacokinetics of Vorinostat Given Orally to Patients with Advanced Cancer
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Linda Sun | 71 | 323 | 606 | 338 | 33 | 783 | |
| M N Chang | 135 | 261 | 265 | 387 | 20 | 938 | |
| Houston Gilbert | 20 | 245 | 256 | 67 | 25 | 759 | |
| R. Angelo de Claro | 40 | 409 | 193 | 138 | 37 | 759 | |
| L. McIntosh | 16 | 293 | 460 | 87 | 22 | 766 | |
| Kit Man Wong | 39 | 224 | 359 | 37 | 32 | 768 | |
| Valérie Méresse | 10 | 331 | 310 | 216 | 23 | 818 | |
| Frédéric Vanhoutte | 8 | 231 | 218 | 180 | 33 | 939 | |
| Catherine Jia | 26 | 133 | 73 | 86 | 24 | 701 | |
| Dominique de Valeriola | 16 | 510 | 297 | 62 | 47 | 873 | |
| Mika Kontro | 17 | 154 | 493 | 407 | 49 | 864 |
All Works
Login with ORCID to disown or claim papers
Loading papers...